Florida Research & Innovation Center
Florida Research & Innovation Center (FRIC) is a biomedical research organization specializing in infectious and inflammatory diseases, immunology, vaccine development, cancer biology, and organ transplantation immunology. The center emphasizes both basic and translational research, investigating mechanisms of disease, host-pathogen and host-tumor interactions, and sex-specific immune mechanisms. FRIC supports research with advanced core facilities in flow cytometry, imaging, and bioinformatics, and provides hands-on education and workforce development in biomedical research.
Industries
N/A
Florida Research & Innovation Center
Florida Research & Innovation Center 9801 SW Discovery Way Port St. Lucie, FL 34987
Services
Provides multi-parameter flow cytometry analysis, cell sorting, experimental consultation, user training, and data analysis support to internal and external researchers.
Offers advanced imaging solutions including confocal, widefield, and preclinical imaging, as well as image analysis and consultation.
Provides multi-parameter flow cytometry analysis, cell sorting, experimental consultation, user training, and data analysis support to internal and external researchers.
Offers advanced imaging solutions including confocal, widefield, and preclinical imaging, as well as image analysis and consultation.
Expertise Areas
- Virology
- Immunology
- Vaccine development
- Cancer immunotherapy
Key Technologies
- Spectral flow cytometry
- Single-cell sequencing
- Computational antigen design
- Monoclonal antibody discovery platforms
Key People
Scientific Director
Senior Director Research Operations
Director, Flow Cytometry Core
Director, Imaging Core
Global Director of Vaccine Development
Assistant Staff
Scientific Director
Senior Director Research Operations
Director, Flow Cytometry Core
Director, Imaging Core
Global Director of Vaccine Development
Assistant Staff
News & Updates
Received for the project 'Development of a broadly reactive hepatitis C virus (HCV) vaccination'.
Conferred for oral presentation at the 8th National Congress of the Italian Society for Virology.
Awarded five-year, $5.6 million as part of NIH’s High-Risk, High-Reward Research Program to study approaches targeting viral pathogens.
Granted by the Global Center for Pathogen and Human Health Research, Cleveland Clinic.
Awarded by the American Brain Tumor Association.
Early-stage philanthropic support has enabled the launch of two independent research programs at the Florida Research & Innovation Center.
Received for the project 'Development of a broadly reactive hepatitis C virus (HCV) vaccination'.
Conferred for oral presentation at the 8th National Congress of the Italian Society for Virology.
Awarded five-year, $5.6 million as part of NIH’s High-Risk, High-Reward Research Program to study approaches targeting viral pathogens.
Granted by the Global Center for Pathogen and Human Health Research, Cleveland Clinic.
Awarded by the American Brain Tumor Association.
Early-stage philanthropic support has enabled the launch of two independent research programs at the Florida Research & Innovation Center.